(Q40498828)

21 September 2017

1 reference

title

Role of the biologics in autoimmunity (English)

1 reference

21 September 2017

2

D A Isenberg

1 reference

21 September 2017

D Kausman

1

1 reference

21 September 2017

language of work or name

1 reference

1 December 1994

1 reference

21 September 2017

1 reference

21 September 2017

volume

3

1 reference

21 September 2017

issue

6

1 reference

21 September 2017

page(s)

461-466

1 reference

https://api.crossref.org/works/10.1177%2F096120339400300606

21 September 2017

1 reference

Biological basis for the clinical use of interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339400300606

Cytokines in tumour therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339400300606

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339400300606

Clinical trials of interferons in multiple sclerosis. What have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339400300606

Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339400300606

Immune thrombocytopenia following alpha-interferon therapy in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339400300606

Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339400300606

Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339400300606

Aberrant expression of HLA-DR antigens by insulin-containing beta-cells in recent-onset type I diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339400300606

Interleukin 2 and interferon-gamma augment anticolon antibody dependent cellular cytotoxicity in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339400300606

Resistance to Recombinant Interferon Alfa-2a in Hairy-Cell Leukemia Associated with Neutralizing Anti-Interferon Antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339400300606

Cytokine therapy of neoplastic and inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339400300606

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339400300606

Autoantibodies to epithelial cells in patients on long-term therapy with leucocyte-derived interferon-alpha (IFN-α)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339400300606

10.1177/096120339400300606

21 January 2018

Identifiers

DOI

0 references

1 reference